Mendelian is dedicated to helping doctors find undiagnosed patients early.

Our mission

We focus on rare and hard to diagnose diseases which affect 1 in 17 people worldwide. Rare diseases can present with a range of complex, disconnected symptoms over the course of a lifetime. This makes them difficult to diagnose, and costly for families, doctors and healthcare providers.

At Mendelian, we’re helping to end the diagnostic odyssey by bringing timely patient insights to primary care. We’re building a future where every patient population can expect the right treatment, from the right specialist, at the right time.

Read our manifesto here

Clinician-led approach

We have worked to understand the daily workflow within medical practices to ensure our tools are easy to use and act on. We strive to make practices more efficient in service of patients and never add to their burden.

Every MendelScan report is backed by decades of clinical experience. Our clinician-led approach has laid the foundation for collaborations with internationally renowned rare disease experts, including Prof. Phil Beales, Dr. and Dr. Derralynn Hughes.

Prof. Phil Beales
Dr. Derralynn Hughes

Evidence based digital health

MendelScan is our expert-guided platform for disease discovery. Over the years, we’ve encoded case finding criteria for hard-to-diagnose diseases into MendelScan’s digital library, ready to apply to any medical record system. Our clinician-driven digital solutions are deployed within the NHS, the largest national healthcare system in the world.

Patient groups

We create ethical solutions that put patients first. Our relationships with patient groups, informs all that we do and ensures we stay connected to patient challenges, needs, and values.

This rare disease diagnostic odyssey is expensive for the health care system and prevents timely access to treatments. Every European Union country has a Rare Disease plan

Chief Medical Officer’s Report 2016: Generation Genome

Mendelian fits into the NHS Long Term Plan and UK Strategy for Rare Diseases

Find out now

The Mendelian team

Dr Peter Fish

CEO

Rudy Benfredj

Advisor, Co-Founder

Fran Garcia

Non-Executive Chairman, Co-Founder

Dr Ignacio Hernandez Medrano

Clinical Advisor, Co-Founder

Dr Will Evans

Clinical Lead

Dr Orlando Buendia

Clinical Operations

Dr Alan Warren

Lead Engineer

Hadley Mahon

Head of Commercial

Jez Stockdale

Head of Strategy

Margot Radicati di Brozolo

Head of Operations

Dr Ghazanfar Khan

Head of Clinical Delivery

Freya Boardman-Pretty

Data Scientist

Clare Sanderson

Communications Lead

Lukyn Gedge

Regulatory Affairs; DPO (Data Protection Officer)

Chanaka Ranawickrema

Business Development Manager

Jack Sams

DevOps Engineer

Daniel Ollerenshaw

Software Engineer

Ryan Samuels

Software Engineer

Dina Molnar

Operations Associate
Get in touch